Risk factors for cervical neoplasia in Denmark

APMIS, Supplement

Volumn 106, Issue 80, 1998, Pages 5-41

  Kjær, Susanne Krüger ^a  

^a INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ANAMNESIS; ARTICLE; CARCINOMA IN SITU; CONTRACEPTION; DENMARK; FEMALE; HERPES SIMPLEX; HERPES SIMPLEX VIRUS; HUMAN; MARRIAGE; MIDDLE AGED; PAPILLOMA VIRUS; RISK FACTOR; SEXUALITY; SMOKING; UTERINE CERVIX TUMOR; VIROLOGY; VIRUS INFECTION; AGED; CANCER RISK; CIGARETTE SMOKING; CIRCUMCISION; DEVELOPING COUNTRY; GENITAL HERPES; GONORRHEA; HIGH RISK POPULATION; MAJOR CLINICAL STUDY; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; SEXUAL INTERCOURSE; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS;

ADULT; AGE FACTORS; CARCINOMA IN SITU; CONTRACEPTION; DENMARK; FEMALE; HERPES SIMPLEX; HUMANS; MARITAL STATUS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; REPRODUCTIVE HISTORY; RISK FACTORS; SEXUAL PARTNERS; SIMPLEXVIRUS; SMOKING; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

CONTRACEPTIVE AGENT;

EID: 0031846562     PISSN: 0903465X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (141)

1. Barrasso R, Coupez F, Ionesco M, de Brux J. Human papillomaviruses and cervical intraepithelial neoplasia: the role of colposcopy. Gynecol Oncol 1987; 27: 197-207.
2. Barton SE, Maddox PH, Jenkins D, Edwards R, Cuzick J, Singer A. Effect of cigarette smoking on cervical epithelial immunity: A mechanism for neoplastic change? Lancet 1988; II (8612): 652-654.
3. Becker TM, Wheeler CM, McGough NS, Parmenter CA, Jordan SW, Stidley CA, McPherson RS, and Dorin MH. Sexually transmitted diseases and other risk factors for cervical dysplasia among Southwestern Hispanic and non-Hispanic white women. JAMA 1994a; 271: 1181-1188.
4. Becker TM, Wheeler CM, McGough NS, Stidley CA, Parmenter CA, Dorin MH, Jordan W. Contraceptive and reproductive risks for cervical dysplasia in Southwestern Hispanic and non-Hispanic white women. Int J Epidemiol 1994b; 23: 913-922.
5. Becker TM, Wheeler CM, McGough NS, Parmenter CA, Stidley CA, Jamison SF, Jordan SW. Cigarette smoking and other risk factors for cervical dysplasia in Southwestern Hispanic and non-Hispanic white women. Cancer Epidemiol Biomarkers Prev 1994c; 3: 113-119.
6. Bosch FX, Cardis E. Cancer incidence correlations: Genital, urinary and some tobacco-related cancers. Int J Cancer 1990: 46: 178-184.
7. Bosch FX, Munoz N, de Sanjosé S, Izarzugaza I, Gili M, Viladiu P, Tormo MJ, Moreo P, Ascunce N, Gonzalez LC, Tafur L, Kaldor JM, Guerrero E, Aristizabal N, Santamaria M, Alonso de Ruiz P, Shah K. Risk factors for cervical cancer in Colombia and Spain. Int J Cancer 1992; 52: 750-758.
8. Bosch FX, Castellsagué X, Muñoz N, de Sanjosé S, Ghafiari AM, González LC, Gili M, Izarzugaza I, Viladiu P, Navarro C, Vergaro A, Ascunce N, Guerrero E, Shah KV. Male sexual behavior and human papillomavirus DNA: Key risk factors for cervical cancer in Spain. J Natl Cancer Inst 1996; 88: 1060-1067.
9. Boyd JT, Doll R. Study of the aetiology of carcinoma of the cervix uteri. Brit J Cancer 1964; 18: 419-434.
10. Breslow NE, Day NE. Statistical methods in cancer research. Vol I. The analysis of case-control studies. International Agency for Research on Cancer. Scientific Publication No 32, IARC, Lyon, 1980.
11. Brinton LA, Fraumeni JF Jr.. Epidemiology of uterine cervical cancer. J Chron Dis, 1986; 39: 1051-1065.
12. Brinton LA, Huggins GR, Lehman HF, Mallin K, Savitz DA, Trapido E, Rosenthal J, and Hoover R. Long-term use of oral contraceptives and risk of invasive cervical cancer. Int J Cancer 1986a; 38: 339-344.
13. Brinton LA, Schairer C, Haenszel W, Stolley P., Lehman HF, Levine R, Savitz DA. Cigarette smoking and invasive cervical cancer. JAMA 1986b;255: 3265-3269.
14. Brinton LA, Hamman RF, Huggins GR, Lehman HF, Levine RS, Mallin K, Fraumeni JF Jr.. Sexual and reproductive risk factors for invasive squamous cell cervical cancer. J Natl Cancer Inst 1987; 79: 23-30.
15. Brinton LA, Reeves WC, Brenes MM, Herrero R, de Brinton RC, Gaitan E, Tenorio F, Garcia M, Rawls WE. Parity as a risk factor for cervical cancer. Am J Epidemiol 1989a; 130: 486-496.
16. Brinton LA, Reeves WC, Brenes MM, Herrero R, Gaitan E, Tenorio F, de Britton RC, Garcia M, Rawls WE. The male factor in the etiology of cervical cancer among sexually monogamous women. Int J Cancer 1989b; 44: 199-203.
17. Brinton LA, Reeves WC, Brenes MM, Herrero R, de Britton RC, Gaitan E, Tenorio F, Garcia M, Rawls WE. Oral contraceptive use and risk of invasive cervical cancer. Int J Epidemiol 1990; 19: 4-11.
18. Brinton LA. Oral contraceptives and cervical neoplasia. Contraception 1991; 43: 581-595.
19. Brinton LA. Epidemiology of cervical cancer- overview. In: The Epidemiology of Cervical Cancer and Human Papillomavirus. Muñoz N, Bosch FX, Shah KV, and Meheus A (eds.). IARC Scientific Publications, No. 119, International Agency for Research on Cancer. Lyon, 1992: pp 3-23.
20. Brisson J, Morin C, Fortier M, Roy M, Bouchard C, Leclerc J, Christen A, Guimont C, Penault F, Meisels A. Risk factors for cervical intraepithelial neoplasia: Differences between low- and high-grade lesions. Am J Epidemiol 1994; 140: 700-710.
21. Brock KE, Berry G, Brinton LA, Kerr C, Maclennan R, Mock PA, Shearman RP. Sexual, reproductive and contraceptive risk factors for carcinoma in situ of the uterine cervix in Sydney. Med J Aust 1989; 150: 125-130.
22. Buckley JD, Harris RW, Doll R, Vessey MP, Williams PT. Case-control study of the husbands of women with dysplasia or carcinoma of the cervix uteri. Lancet 1981; 2: 1010-1015.
23. Cevenini R, Costa S, Rumpianesi F, Donati M, Guerra B, Diana R, Antonini MP. Cytological and histopathological abnormalities of the cervix in genital Chlamydia trachomatis infections. Br J Yen Dis 1981; 57: 334-337.
24. Clemmesen IH, Storm HH. Cancer in Denmark. Danish Cancer Society, 1993.
25. Coker AL, Jenkins GR, Busnardo MS, Chambers JC, Levine LZ, Pirisi L. Human papillomaviruses and cervical neoplasia in South Carolina. Cancer Epidemiol Biomarkers Prev 1993; 2: 207-212.
26. Crook T, Vousden KH. HPV oncoprotein function. In: Papillomavirus Reviews: Current research on papillomaviruses. C Lacey (eds.) Department of Genitourinary Medicine & Communicable Diseases, St. Mary's Hospital Medical School, London W2 1NY, UK, Leeds University Press, 1996: pp 55-60.
27. Cullen AP, Reid R, Campion M, Lörincz AT. Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm. J Virol 1991; 65: 606-612.
28. Cullen TS (ed). Cancer of the uterus. New York: Appleton, 1900.
29. Cuzick J, De Stavola BL, McCance D, Ho TH, Tan G, Cheng H, Chew SY, Salmon YM. A case-control study of cervix cancer in Singapore. Br J Cancer 1989; 60: 238-243.
30. Cuzick J, Singer A, De Stavola BL, Chomet J. Case-control study of risk factors for cervical intraepithelial neoplasia in young women. Eur J Cancer 1990; 26: 684-690.
31. Czegledy J, Gergely L, Endröedi I. Detection of human papillomavirus deoxyribonucleic acid by filter in situ hybridization during pregnancy. J Med Virol 1989; 28: 250-254.
32. Daling JR, Sherman KJ, Hislop TG. Cigarette smoking and the risk of anogenital cancer. Am J Epidemiol 1992; 135: 180-189.
33. de Roda Husman AM, Walboomers JMM, Meijer CJLM, Risse EKJ, Schipper MET, Heimerhorst THM, Bleker OP, Van den Brule AJC, Snijder PJF. Analysis of cytomorphologically abnormal cervical scrapes for the presence of 27 mucosotropic human papillomavirus genotypes using polymerase chain reaction. Int J Cancer 1994; 56: 802-806.
34. de Roda Husman AM, Walboomers JMM, Hopman E, Bleker OP, Heimerhorst TM J, Rozendaal L, Voorhorst FJ, Meijer CJLM. HPV prevalence in cytomorphologically normal cervical scrapes of pregnant women as determined by PCR: The age-related pattern. J Med Virol 1995; 46: 97-102.
35. de Vet HCW, Sturmans F. Risk factors for cervical dysplasia: implications for prevention. Public Health 1994; 108: 241-249.
36. de Villiers E.-M. Human pathogenic papillomavirus types: an update. Current Top Microbiol Immunol 1994; 186: 1-12.
37. Donnan SPB, Wong FWS, HO SC, Lau EMC, Takashi K, Esteve J. Reproductive and sexual risk factors and human papillomavirus infection in cervical cancer among Hong Kong Chinese. Int J Epidemiol 1989; 18: 32-36.
38. Dyson N, Howley PM, Munger K, Harlow E. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 1989; 243: 934-937.
39. Franco El, Campos-Filho N, Villa LL, Torloni H. Correla-tion patterns of cancer relative frequencies with some socioeconomic and demographic indicators in Brazil: an ecologie study. Int J Cancer 1988; 41: 24-29.
40. Gloss B, Bernard H-U, Seedorf K, Klock G. The upstream regulatory region of the human papillomavirus-16 contains an E2 protein-independent enhancer which is specific for cervical carcinoma cells and regulated by glucocorticoid hormones. EMBO1987; 6: 3735-3743.
41. Graham S, Priore R, Graham M, Browne R, Burnett W, West D. Genital cancer in wives of penile cancer patients. Cancer 1979; 44: 1870-1874.
42. Graham S, Rawls W, Swanson M, McCurtis J. Sex partners and herpes simplex virus type 2 in the epidemiology of cancer of the cervix. Am J Epidemiol 1982; 115: 729-735.
43. Herrero R, Brinton LA, Reeves WC, Brenes MM, Tenoroi F, de Britton RC, Gaitan E, Garcia M, Rawls WE. Sexual behavior, venereal diseases, hygiene practices, and invasive cervical cancer in a high-risk population. Cancer 1990; 65: 380-386.
44. Hildesheim A, Brinton LA, Mallin K, Lehman HF, Stolley P, Savitz DA, Levine R. Barrier and spermicidal contraceptive methods and risk of invasive cervical cancer. Epidemiology 1990; 1: 266-272.
45. Ho GYF, Burk RD, Klein D, Kadish AS, Chang CJ, Palan P, Basu J, Tachezy R, Lewis R, Romney S. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst 1995; 87: 1365-1371.
46. Howley PM. Role of the human papillomaviruses in human cancer. Cancer Res 1991; 51: 5019-5022.
47. International Agency for Research Cancer. Human Papillomaviruses. Monographs on the Evaluation of the Carcinogenic Risks to Humans. Vol. 64.1 ARC, Lyon, 1995.
48. Irwin KL, Rosero-Bixby L, Oberle MW, Lee NC, Whatly AS, Fortney JA, Bonhomme MG. Oral contraceptives and cervical cancer risk in Costa Rica: Detection bias or causal association? JAMA 1988; 259: 59-64.
49. Jones CJ, Brinton CJ, Hamman RF, Stolley PD, Lehman HF, Levine RS, Malin K. Risk factors for in situ cervical cancer: results from a case-control study. Cancer Res 1990; 50: 3657-3662.
50. Jussawalla DJ, Deshpande VA, Standfast SJ. Assessment of risk patterns in cancer of the cervix: A comparison between greater Bombay and Western countries. Int J Cancer 1971; 7: 259-268.
51. Kemp AE, Hakenewerth AM, Laurent SL, Gravitt PE, Stoerker J. Human papillomavirus prevalence in pregnancy. Obstet & Gynecol 1992; 79: 649-656.
52. Kirnbauer R, Taub J, Greenstone H, Roden R, Dürst M, Gissmann L, Lowy DR, Schiller JT. Efficient self-assembly of human papillomavirus types 16 LI and L1-L2 into virus-like particles. J Virol 1993; 67: 6929-6936.
53. Kiviat NB, Critchlow CW, and Kurman RJ. Reassessment of the morphological continuum of cervical intraepithelial lesions: does it reflect different stages in the progression to cervical carcinoma? In: The Epidemiology of Cervical Cancer and Human Papillomavirus. Muños, N, Bosch, FX, Shah KV and Meheus A (eds). Scientific Publication No. 119. International Agency for Research on Cancer, Lyon, 1992: pp 59-66.
54. Kjær SK, de Villiers EM, Haugaard BJ, Christensen RB, Teisen C, Møller KA, Poll P, Jensen H, Vestergaard BF, Lynge E, and Jensen OM. Human papillomavirus, herpes simplex virus and cervical cancer incidence in Greenland and Denmark. A population-based cross-sectional study. Int J Cancer 1988; 41: 518-524.
55. Kjær SK, de Villiers E.-M., Dahl C, Engholm G, Bock JE, Vestergaard BF, Lynge E, Jensen OM. Case-control study of risk factors for cervical neoplasia in Denmark. I: Role of the "male factor" in women with one lifetime sexual partner. Int J Cancer 1991; 48: 39-44.
56. Kj́r SK, Dahl C, Engholm G, Bock JE, Lynge, Jensen OM. Case-control study of risk factors for cervical neoplasia in Denmark. II: Role of sexual activity, reproductive factors, and venereal infections. Cancer Causes and Control 1992; 3: 339-348.
57. Kjær SK, de Villiers EM, Calayan H, Svare E, Haugaard BJ, Engholm G, Christensen RB, Møller KA, Poll P, Jensen H, Vestergaard BF, Lynge E, Jensen OM. Human Papillomavirus, Herpes simplex virus and other potential risk factors for cervical cancer in a high-risk area (Greenland) and a low-risk area (Denmark) - a second look. Br J Cancer 1993a; 67: 830-37.
58. Kjæ SK, Engholm G, Dahl C, Bock JE, Lynge E, Jensen OM. Case-control study of risk factors for cervical squamous-cell neoplasia in Denmark. III: Role of oral contraceptive use. Cancer Causes and Control 1993b; 4: 513-519.
59. Kjær SK, Svare EI, Worm AM, Meijer CJLM, Walboomers JMM, van den Brule AJC. Genital human papillomavirus infection in prostitutes from Copenhagen. (Abstract) 14th International Papillomavirus Conference, Quebec 1995.
60. Kjær SK, Engholm G, Dahl C, Bock JE. Case-control study of risk factors for cervical squamous cell neoplasia in Denmark. IV: Role of smoking habits. Eur J Cancer Prev 1996a; 5: 359-365.
61. Kjær SK, Van den Brule AJC, Bock JE, Poll PA, Engholm G, Sherman ME, Walboomers JMM, and Meijer CJLM. Human papillomavirus- the most significant risk determinant of cervical intraepithelial neoplasia. Int J Cancer 1996b; 65: 601-606.
62. Koss LG, Wolinska WH. Trichomonas vaginalis cervicitis and its relationship to cervical cancer. Cancer 1959; 12: 1171-1193.
63. Koss LG. Current concepts of intraepithelial neoplasia in the uterine cervix. Appl Pathol 1987; 5: 7-18.
64. Koutsky LA, Holmes KK, Critchlow CW, Stevens CE, Paavonen J, Beckmann AM, DeRouen TA, Galloway DA, Vernon D. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med 1992; 327: 1272-1278.
65. la Vecchia C, Franceschi S, Decarli A, Fasoli M, Gentile A, Parazzini F, Regallo M. Sexual factors, venereal diseases, and the risk of intraepithelial and invasive cervical neoplasia. Cancer 1986a; 58: 935-941.
66. la Vecchia C, Francheschi S, Decarli A, Fasoli M, Gentile A, Tognoni G. Cigarette smoking and the risk of cervical neoplasia. Am J Epidemiol 1986b; 123: 22-9.
67. Lehtinen M, Hakama M, Aaran RK, Aromaa A, Knekt P, Leinikki P, Maatela J, Peto R, Teppo L. Herpes simplex virus type-2 infection and cervical cancer: a prospective study of 12 years of follow-up in Finland. Cancer Causes and Control 1992; 3: 333-338.
68. Lidegaard Ø. Use of oral contraceptives in Denmark from 1980-1990 and smoking habits among fertile women in 1990. Ugeskr Laeger 1993; 3550-3558.
69. Lynge E, Jensen OM. Cohort trends in incidence of cervical cancer in Denmark in relation to gonorrhoeal infection. Acta Obstet Gynecol Scand 1985; 64: 291-296.
70. Mandelson MT, Daling JT, White E, Chu J, McKnight B. Further evidence that duration and recency of oral contraceptive use are associated with invasive cervical cancer (Abstract). Am J Epidemiol 1990; 132: 77B.
71. Manos MM, Ting Y, Wright DK, Lewis AJ, Broker TR, Wolinsky SM. Use of polymerase-chain-reaction amplification for the detection of genital human papillomaviruses. In: Furth M, and Greaves M (eds), Molecular diagnostics of human cancer, Cancer Cells 7. Cold Spring Habor Laboratory, New York, 1989: pp 209-14.
72. Martinez I. Relationship of squamous cell carcinoma of the cervix uteri to squamous cell carcinoma of the penis among Puerto Rican women married to men with penile carcinoma. Cancer 1969; 24: 777-780.
73. Meisels A, Fortin R. Condylomatous lesions of the cervix and vagina. I. Cytologic patterns. Acta Cytol 1976; 20; 505-509.
74. Meisels A, Fortin R, Roy M. Condylomatous lesions of the cervix. II. Cytologic colposcopic and histopathologic study. Acta Cytol 1977; 21: 379-390.
75. Melkert PJW, Hopman E, van den Brule A JC, Risse EKJ, van Diest PJ, Bleker OP, Helmerhorst T, Schipper MEI, Meijer CJLM, Walboomers JMM. Prevalence of HPV in cytomorphologically normal cervical smears as determined by PCR is age-dependent. Int J Cancer 1993; 53: 919-923.
76. Mittal R, Pater A, Pater MM. Multiple human papillomavirus type 16 glucocorticoid response elements functional for transformation, transient expression, and DNA-protein interactions. J Virol 1993; 67: 5656-5659.
77. Mitrani-Rosenbaum S, Tsvielli R, Tur-Kaspa R. Oestrogen stimulates differential transcription of human papillomavirus type 16 in SiHa cervical carcinoma cells. J Gen Virol 1989; 70: 2227-2232.
78. Monsonego J, Magdalenat H, Catalan F, Coscas Y, Zerat L, Sastre X. Estrogen and progesterone receptors in cervical human papillomavirus related lesions. Int J Cancer 1991; 48: 533-539.
79. Molina R, Thomas DB, Dabancens A, Lopez J, Ray RM, Martinez L, Salas O. Oral contraceptives and cervical carcinoma in situ in Chile. Cancer Res 1988; 48: 1011-1015.
80. Morrison EAB, Ho GYF, Vermund SH, Goldberg GL, Kadish AS, Kelley KF, Burk RD. Human papillomavirus infection and other risk factors for cervical neoplasia: a case-control study. Int J Cancer 1991; 49: 6-13.
81. Muñoz N, Bosch FX, Kaldor JM. Does human papillomavirus cause cervical cancer? The state of the epidemiological evidence. Br J Cancer 1988; 57: 1-5.
82. Muñoz N, Bosch FX, de Sanjosé S, Vergara A, del Moral A, Muñoz MT, Tafur L, Gili M, Izarzugaza I, Viladiu P, Navarro C, Alonso de Ruiz P, Aristizabal N, Santamaria M, Orfila J, Daniel RW, Guerrero E, Shah KV. Risk factors for cervical intraepithelial neoplasia grade III/carcinoma in situ in Spain and Colombia. Cancer Epidemiology, Biomarkers & Prevention 1993; 2: 423-431.
83. Muñoz N, Castellsagué X, Bosch FX, Tafur L, de Sanjosé S, Aristizabal N, Ghafiari AM, Shah KV. Difficulty in elucidating the male role in cervical cancer in Colombia, a high-risk area for the disease. J Nat Cancer Inst 1996; 88: 1068-1075.
84. Najem SN, Vestergaard BF, Potter CW. Herpes simplex virus type-specific antibodies detected by indirect and competition ELISA. Comparison of sera from patients with carcinoma of the uterine cervix, age matched controls and patients with recurrent genital herpes. Acta Path Microbiol Immunol Scand 1983; 91: 205-207.
85. NCI. National Cancer Institute Workshop: the 1988 Bethesda system for reporting cervical/vaginal cytology diagnoses. JAMA 1989; 262: 931-934.
86. Negrini BP, Schiffman MH, Kurman RJ, Barnes W, Lannom L, Malley K, Brinton LA, Delgado G, Jones S, Tchabo JG, Lancanster WD. Oral contraceptive use, human papillomavirus infection, and risk of early cytological abnormalities of the cervix. Cancer Res 1990; 50: 4670-4675.
87. Oriel JD. Natural history of genital warts. Br J Vener Dis 1971; 47: 1-13.
88. Papanicolaou GN. A survey of the actualities and potentialities of exfoliative cytology in cancer diagnosis. Ann Med 1948; 30: 661-674.
89. Parazzini F, La Vecchia C, Negri E, Maggi R. Oral contraceptive use and invasive cervical cancer. Int J Epidemiol 1990; 2: 259-263.
90. Parazzini F, La Vecchia C, Negri E, Fedele L, Franceschi S, Gallotta L. Risk factors for cervical intraepitelial neoplasia. Cancer 1992; 69: 2276-2282.
91. Parkin DM, Läärä E, Muir CS. Estimates of the worldwide frequency of sixteen major cancers in 1980. Int J Cancer 1988; 41: 184-197.
92. Parkin DM, Muir CS, Whelan SL, Gao YT, Ferlay J, and Powell J (eds.). Cancer Incidence in Five Continents, Vol. VI. IARC Scientific Publication, No. 120, International Agency for Research on Cancer, Lyon, 1992.
93. Pater A, Bayatpour M, Pater MM. Oncogenic transformation by human papillomavirus type 16 deoxyribonucleic acid in the presence of progesterone or progestins from oral contraceptives. Am J Obstet Gynecol 1990; 162: 1099-1103.
94. Payne RW, Lane PW, Ainsley AE, Bicknell KE, Digby PGN, Harding SA, Leech PK, Simpson HR, Todd AD, Verrier PJ, White RP, Gower JC, Wilson GT, Paterson LJ. GENSTAT 5 reference manual. Rothamsted Experimental Station Oxford, 1987.
95. Peng H, Liu S, Mann V, Rohan T, Rawls W. Human papillomavirus types 16 and 33, herpes simplex virus type 2 and other risk factors for cervical cancer in Sichuan Province, China. Int J Cancer 1991; 47: 711-716.
96. Peters RJ, Thomas D, Hagan DG, Mack TM, Henderson BE. Risk factors for invasive cervical cancer among La-tinas and Non-Latinas in Los Angeles country. J Natl Cancer Inst 1986; 77: 1063-1077.
97. Phillips AN, Smith GD. Cigarette smoking as a potential cause of cervical cancer: has confounding been controlled? Int J Epidemiol 1994; 23: 42-49.
98. Piper JM. Oral contraceptives and cervical cancer. Gynecol Oncol 1985; 22: 1-14.
99. Rando RF, Lindheim S, Hasty L, Sedlacek TV, Woodland M, Eder C. Increased frequency of detection of human papillomavirus deoxyribonucleic acid in exfoliated cervical cells during pregnancy. Am J Obstet Gynecol 1989; 161: 50-55.
100. Reagan JW, Harmonic MJ. Dysplasia of the uterine cervix. Ann N Y Acad Sci 1956; 63: 662-682.
101. Richart RM. Natural history of cervical intraepithelial neoplasia. Clin Obstet Gynecol 1968; 10: 748-784.
102. Richart RM. Cervical intraepithelial neoplasia: a review. Pathol Ann 1973; 8: 301-328.
103. Rosenfeld WD, Rose E, Vermund SH, Schreiber K, Burk RD. Follow-up evaluation of cervicovaginal human papillomavirus infection in adolescents. J Pediatr 1992; 121: 307-11.
104. Rotkin ID. A comparison review of key epidemiological studies in cervical cancer related to current searches for transmissible agents. Cancer Res 1973; 33: 1353-1367.
105. Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, Mullis KB, Erlich HA. Primer-directed enzymatic amplification on DNA with thermostable DNA polymerase. Science 1988; 239: 487-491.
106. Schachter J, Hill EC, King EB, Heilbron DC, Ray RM, Margolis AJ, Greenwood SA. Chlamydia trachomatis and cervical neoplasia. JAMA, 1982; 248: 2134-2138.
107. Schiffman MH, Haley HJ, Felton JS, Andrews AW, Kaslow RA, Lancaster WD, Kurman RJ, Brinton LA, Lannom LB, Hoffmann D. Biochemical epidemiology of cervical neoplasia: Measuring cigarette smoke constituents in the cervix. Cancer Res 1987; 47: 3886-3888.
108. Schiffman MH, Bauer HM, Hoover RN, Glass AG, Cadell DM, Rush BB, Scott DR, Sherman ME, Kurman, Wacholder S, Stanton CK, Manos MM. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 1993; 85: 958-964.
109. Schiller JT, Roden RBS. Papillomavirus-like particles. Papillomavirus Report 1995; 6: 121-128.
110. Schneider A, Hotz M, Gissmann L. Increased prevalence of human papillomavirus in the lower genital tract of pregnant women. Int J Cancer 1987; 40: 198-201.
111. Schneider A, Sterzik K, Buck G, de Villiers E-M. Colposcopy is superior to cytology for the detection of early human papillomavirus infection. Obstet Gynecol 1988; 71: 236-241.
112. Schneider A, Koutsky LA. Natural history and epidemiological features of genital HPV infection: In: The Epidemiology of Cervical Cancer and Human Papillomavirus. Munoz N, Bosch FX, Shah KV, and Meheus A (eds). I ARC Scientific Publications, No. 119. International Agency for Research on Cancer, Lyon, 1992: pp 25-52.
113. Schneider A. Genital HPV infections In: Papillomavirus Reviews: Current research on papillomaviruses. C Lacey (eds.) Department of Genitourinary Medicine & Communicable Diseases, St.' Mary's Hospital Medical School, London W2 1NY, UK, Leeds University Press, 1996: pp 207-214.
114. Simons AM, Phillips DN, Coleman DV. Damage to DNA in cervical epithelium related to smoking tobacco. Br Med J 1993; 306: 1444-1448.
115. Simons AM, van Herckenrode CM, Rodriguez JA, Maitland N, Anderson M, Philips DH, Coleman DV. Demonstration of smoking-related DNA damage in cervical epithelium and correlations With human papillomavirus type 16, using exfoliated cervical cells. Br J Cancer 1995; 71: 246-249.
116. Skegg DCG, Corwin PA, Paul C, Doll R. Importance of the male factor in cancer of the cervix. Lancet 1982; 2: 581-583.
117. Slattery ML, Overall JC Jr., Abott TM, French TK, Robison LM, Gardner J. Sexual activity, contraception, genital infections, and cervical cancer: Support for a sexually transmitted disease hypothesis. Am J Epidemiol 1989; 130: 248-258.
118. Soares VRX, Nieminen P, Aho M, Vesterinen E, Vaheri A, Paavonen J. Human papillomavirus DNA in unselected pregnant and non-pregnant women. Int J STD & AIDS 1990; 1: 276-278.
119. Storm HH. Completeness of cancer registration in Denmark 1943-1966 and efficacy of record linkage procedures. Int J Epidemiol 1988; 17: 44-49.
120. Storm HH. The Danish Cancer Registry. A self reporting national cancer registration system with elements of active data collection. In: Jensen OM et al. (eds). Cancer Registration, Principles and Methods. IARC Scientific publications Vol 95. International Agency for Research on Cancer, Lyon 1991.
121. Storm HH, Manders T, Lecker S. Cancer Incidence in Denmark 1991. Danish Cancer Society, 1994.
122. Swan SH, Petitti DB. A review of problems of bias and confounding in epidemiologic studies of cervical neoplasia and oral contraceptive use. Am J Epidemiol 1982; 115: 10-18.
123. Syrjänen KJ. Natural history of genital human papillomavirus infections. In: Papillomavirus Reviews: Current research on papillomaviruses. C Lacey (eds). Department of Genitourinary Medicine & Communicable Diseases, St. Mary's Hospital Medical School, London, UK, Leeds University Press, 1996: pp 207-214.
124. van den Brule A JC, Meijer CJLM, Bakels V, Kenemans P, Walboomers JMM. Rapid detection of human papillomavirus in cervical scrapes by combined general-primermediated and type-specific polymerase chain reaction. J Clin Microbiol 1990a; 28: 2739-2743.
125. van den Brule AJC, Snijders PJF, Gordijn RLJ, Bleker OP, Meijer CJLM, Walboomers JMM. General-primer mediated polymerase chain reaction permits the detection of sequenced and still unsequenced human papillomavirus genotypes in cervical scrapes and carcinomas. Int J Cancer 1990b; 45: 644-649.
126. Vestergaard BF, Grauballe PC. ELISA for herpes simplex virus (HSV) type-specific antibodies in human sera using HSV type 1 and type 2 polyspecific antigens blocked with type-heterologous rabbit antibodies. Acta Path Microbiol Scand. 1979; 87: 261-263.
127. Vestergaard BF. Antigens and antibodies in viral disease. In: E Bergmeyer (ed.). Methods of enzymatic analysis. Vol. X, VCH, Weinheim, Germany, 1986: pp 226-42.
128. Vonka V, Kanka J, Hirsch I, Zavadova H, Krcmar M, Suchankova A, Rezacova D, Broucek J, Press M, Domorazkova E, Svoboda B, Havrankova A, Jelinek J. Prospective study on the relationship between cervical neoplasia and herpes simplex type-2 virus. II. Herpes simplex type-2 antibody presence in sera taken at enrollment. Int J Cancer, 1984; 33: 61-66.
129. Vonka V, Kanka J, Roth Z. Herpes simplex type 2 virus and cervical neoplasia. Adv Cancer Res 1987; 48: 149-191.
130. Walboomers JMM, De Roda Husman AM, Van den Brule AJC, Snijders PJF, Meijer CJLM. Detection of genital human papillomavirus infections: Critical review of methods and prevalence studies in relation to cervical cancer. In: Stem PL and Stanley MA (eds.), Human Papillomaviruses and cervical cancer. Biology and Immunology, Oxford University Press, 1994: pp 41-71.
131. Williams MA, Kenya PR, Mati JKG, Thomas DB. Risk factors for invasive cervical cancer in Kenyan women. Int J Epidemiol 1994; 23: 906-912.
132. Winkelstein Jr W. Smoking and cervical cancer-current status: a review. Am J Epidemiol 1990; 131: 945-957.
133. Wright TC Jr., Kurman RJ. A critical review of the morphologic classification systems of preinvasive lesions of the cervix: the scientific basis for shifting the paradigm. In: Papillomavirus Reviews: Current research on papil-lomaviruses. C Lacey (eds.) Department of Genitourinary Medicine & Communicable Diseases, St. Mary's Hospital Medical School, London W2 1NY, UK, Leeds University Press, 1996: pp 215-227.
134. Zaninetti P, Franceschi S, Baccolo M, Bonazzi B, Gottardi G, Serraino D. Characteristics of women under 20 with cervical intraepithelial neoplasia. Int J Epidemiol 1986; 15: 477-482.
135. Zhang ZF, Begg CB. Is Trichomonas vaginalis cause of cervical neoplasia? Results from a combined analysis of 24 studies. Int J Epidemiol 1994; 23: 682-690.
136. Zunzunegui MV, King MC, Coria CF, Charlet J. Male influences on cervical cancer risk. Am J Epidemiol 1986; 123: 302-307.
137. Zur Hausen H. Human papillomaviruses and their possible role in squamous cell carcinomas. Curr Top Microbiol Immunol 1977; 78: 1-30.
138. Zur Hausen H. Human genital cancer: synergism between two virus infections or synergism between a virus infection and initiating events? Lancet 1982; II: 1370-1372.
139. Zur Hausen H. Human papillomaviruses in the pathogenesis of anogenital cancer. Virology 1991: 184; 9-13.
140. Zur Hausen H. Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types. Curr Top Microbiol Immunol 1994; 186: 131-156.
141. Østerlind A, Jensen OM. Evaluation of registration of cancer cases in Denmark in 1977: preliminary evaluation of registration of cancer cases by the Cancer Registry and the National Patient Registry. Ugesk Laeger 1985; 147: 2483-2488 (in Danish).